The PK Characteristics of the Co-administration of Rosuvastatin and Telmisartan/Amlodipine and JLP-1401 in Healthy Adult Volunteers Volunteers
Clinical trial NCT03707899 · COMPLETED
Trial details
- NCT number
- NCT03707899
- Sponsor
- Jeil Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-13
- Primary completion
- 2019-02-18
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.